ArticleCase reports in oncology
Large Thoracic Solitary Fibrous Tumor: A Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: A solitary fibrous tumor (SFT) is a type of soft-tissue sarcoma capable of extensive growth, potentially involving adjacent tissues. We present an unusually large SFT case with minimal clinical symptoms, highlighting the diagnostic challenges posed by its size in relation to its benign presentation. Case Presentation: We present a case of a 73-year-old male admitted to the hospital with a sensation of heaviness in the epigastric region and shortness of breath when lying on his left side. Computed tomography revealed a large left hemithorax mass, which was successfully excised. This case exemplifies the right approach to managing a large thoracic SFT, highlighting successful treatment and the role of the patient's self-care in the outcome. We considered minimally invasive video-assisted thoracoscopic surgery alone, upfront thoracotomy, and even alternatives like preoperative embolization, but a staged strategy was chosen as the safest, because of limited visualization and size. Conclusion: Our case highlights that even giant STFs may stay clinically silent, it underscores that size alone is not predictive for clinical manifestation. Patient's self-care and early manifestation may become a life-changing aspect, just because size and symptoms do not correlate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.